Highlights of ASH in Asia

Last Modified: January 17, 2013

Dates: March 23-24, 2013
Location: Shanghai, China

Sponsoring Group: The American Society of Hematology

Web Page URL: www.hematology.org/calendar_HOAAsia

Topics Covered: Acute Myeloid Leukemia Bone Marrow Failure Chronic Lymphocytic Leukemia Disorders of Hemostasis Hematopoietic Stem Cell Transplantation Hodgkin and Non-Hodgkin Lymphoma Myelodysplastic Syndromes Myeloproliferative Neoplasms Including Chronic Myeloid Leukemia Novel Treatments for Relapsed/Refractory Chronic Immune Thrombocytopenia Plasma Cell Disorders (Myeloma) Thrombosis and Anticoagulation Thrombotic Thrombocytopenic Purpura (TTP)/Hemolytic Uremic Syndrome (HUS) and Atypical HUS

Objectives: At Highlights of ASH you will:

  • Examine advances in clinical and translational hematologic research
  • Evaluate the role of new diagnostic techniques and therapeutic approaches as applied to the care and management of people with blood diseases
  • Discuss new patient management and care strategies with leading faculty in the field

Fees: $125-275

Continuing Education: No

Blogs

Hand Washing Saves Patients' Lives
by Rodney Warner, JD
January 20, 2015

Homeopathy: What You Should Know
by The 4Wholeness Team
July 22, 2015

Related News

ASH: Hodgkin's Lymphoma Tx Shows Promise in Small Trial

Dec 9, 2014

Nivolumab harnesses power of immune system in patients who've failed other therapy


ASH: Carfilzomib Ups Survival in Relapsed Multiple Myeloma

Dec 9, 2014

Improved progression-free survival with addition of carfilzomib to lenalidomide and dexamethasone


ASH: CALR Mutations ID'd in Myeloproliferative Neoplasms

Dec 11, 2013

Two studies show somatic mutations in CALR for most patients with nonmutated JAK2